Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Completed · Phase 2

Conditions studied: Alzheimer Disease

In brief

To access the safety, tolerability, and immunogenicity of ACC-001, an investigational active immunization, in subjects with mild to moderate Alzheimer's disease.

Key facts

Study ID
NCT00498602
Run by
Pfizer
People needed
160
Starts
2007-11-01
Expected to finish
2013-02-01
Last updated by the study team
2016-01-01

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.